anti-chikv hyperimmune immunoglobulins

Biologicalexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Sep 1, 2014 (NCT02230163)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • anti-chikv hyperimmune immunoglobulins

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02230163Phase 1/Phase 2 (Phase 2)Sep 1, 2014Centre Hospitalier Universitaire de Pointe-a-Pitre
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Centre Hospitalier Universitaire de Pointe-a-PitreAcademic/Hospital1112014
1 organizations
Page 1 / 1